Log In
No results found for "".

Commentary & Deal Flow

NEW ISSUE: Thermo Fisher Scientific CHF bmk 3yr, 6yr, 9yr & 12yr Sr Unsec; SARON MS+65/75bp & SARON MS+80/90bp & SARON MS+95/105bp & SARON MS+105/115bp

IGC European Market: Deal Flow - General

Issuer

Term

Maturity

Size

Ranking

Type

IPT

Thermo Fisher Scientific

3yr

12-Nov-29

bmk

Sr Unsec

Fixed

SARON MS+65/75

Thermo Fisher Scientific

6yr

12-Nov-32

bmk

Sr Unsec

Fixed

SARON MS+80/90

Thermo Fisher Scientific

9yr

12-Nov-35

bmk

Sr Unsec

Fixed

SARON MS+95/105

Thermo Fisher Scientific

12yr

12-Nov-38

bmk

Sr Unsec

Fixed

SARON MS+105/115


IPTs: 3yr: SARON MS+65/75bp 6yr: SARON MS+80/90bp 9yr: SARON MS+95/105bp 12yr: SARON MS+105/115bp


  • Issuer: Thermo Fisher Scientific Inc.
  • Ticker: TMO
  • Issuer Domicile: United States of America
  • Format: Public Fixed Rate Notes
  • Status: Senior Unsecured Debt
  • Issuer Rating: Moodys: A2 (st.) / S&P: A- (st.) / Fitch: A- (st.)
  • Instrument Rating (exp): Moodys: A2 / S&P: A- / Fitch: A-
  • Coupon:
    • 3yr: 1.09% p.a. (indicative), will price at par
    • 6yr: 1.36% p.a. (indicative), will price at par
    • 9yr: 1.6025% p.a. (indicative), will price at par
    • 12yr: 1.79% p.a. (indicative), will price at par
  • Maturity:
    • 3yr: 3 years (12-Nov-26 until 12-Nov-29, including 1 month par call)
    • 6yr: 6 years (12-Nov-26 until 12-Nov-32, including 3 month par call)
    • 9yr: 9 years (12-Nov-26 until 12-Nov-35, including 3 month par call)
    • 12yr: 12 years (12-Nov-26 until 12-Nov-38, including 3 month par call)
  • Spread/Yield:
    • 3yr: SARON MS +65.0 /+75.0 // YTM 1.09% /1.19% // Govt.+79 /+89
    • 6yr: SARON MS +80.0 /+90.0 // YTM 1.36% /1.46% // Govt.+96 /+106
    • 9yr: SARON MS +95.0 /+105.0 // YTM 1.603% /1.703% // Govt.+117 /+127
    • 12yr: SARON MS +105.0 /+115.0 // YTM 1.79% /1.89% // Govt.+128 /+138
  • Lead Manager(s): DB, BNP, UBS
  • SNB Repo-eligibility: At the discretion of the SNB, expected no
  • Documentation: Standalone CHF documentation, including a Long Form Term Sheet dated 2-Nov-26.
  • FinSA Prospectus: Prospectus approval post-settlement only, in accordance with art. 51 Swiss Financial Services Act of 15-Jun-18
  • Governing Law: Swiss Law
  • Use of Proceeds: Repayment of outstanding indebtedness and other general corporate purposes, which may include the acquisition of companies or businesses, the refinancing of debt, working capital and capital expenditures and the repurchase of outstanding equity securities, or the Issuer may temporarily invest some or all of the net proceeds from the sale of the Bonds in short-term, liquid investments until the net proceeds are used for their ultimate purpose
  • Covenants: PP, limitation on liens and sale and leaseback transactions, XD
  • Early Redemption: Clean Up Call at par at 75%, 1 Month Par Call on Tranche 1, 3 Month Par Call on Tranches 2/3/4, Redemption for Tax Reasons, Change of Control Put
  • SIX Listing: 10-Nov-26
  • Denomination: CHF 5000 and multiples thereof
  • Sales Restrictions: The Bonds are subject to restrictions on the offering, sale and delivery both generally and specifically in the United States of America and to U.S. persons, the EEA and UK.
  • Target Market: Manufacturer target market (MiFID II / UK MIFIR product governance) is eligible counterparties and professional clients only (all distribution channels). Prohibition of Sales to EEA/UK Retail Investors restrictions apply, public offering in Switzerland only.
  • Retail Restrictions: EEA & UK domiciled: Applicable Other: Subject to applicable regulations and restrictions.
  • Timing: Today's business